SYMPOSIUM: Immuno-Oncology and Inflammation; Discovering New Scientific Frontiers

June 20, 2018: 09:00 - 17:00
Janssen Research Campus, Beerse, Belgium.

Crown/JnJ symposium

Crown Bioscience and Janssen Pharmaceutica cordially invite you to a jointly organized symposium on Immuno-Oncology and Inflammation; Discovering New Scientific Frontiers on June 20th.

Internationally renowned speakers from academia and industry will discuss the latest developments in molecular mechanisms of inflammation and immuno-oncology, disease models and therapeutic applications.

Presentations & Speakers

Stef Heylen
Stef Heylen

Chief Operating Officer
Janssen R&D
Managing Director - Chairman of the Management Board
Janssen Pharmaceutica NV
Opening Remarks
9:15 AM

Pieter Peeters
Pieter Peeters

Senior Director Computational Biology Janssen
9:00 AM

Jacques Neefjes
Jacques Neefjes

Head of Department of Cell and Chemical Biology
Leiden University Medical Center
Understanding and manipulating anthracycline anti-cancer drugs and their immune modulatory effects
10:00 AM

Esteban Ballestar
Esteban Ballestar

Group Leader, Cancer Epigenetics and Biology Programme (PEBC)
Bellvitge Biomedical Research Institute (IDIBELL)
The tumour microenvironment targets epigenetic alterations in immune cells
2:00 PM

Manolis Pasparakis
Manolis Pasparakis

Cluster of Excellence CECAD and Institute for Genetics
RIP kinase signalling in cell death and inflammation
9:30 AM

Cem Gabay
Cem Gabay

Director of the Department of Internal Medicine Specialities
University of Geneva
The IL-18/IL-18BP balance in systemic inflammation
10:30 AM

Martin Sos
Martin Sos

Group Leader Molecular Pathology and Translational Genomics
University of Cologne
Targeting molecular dependencies in lung cancer
2:30 PM

Sebastian Amigorena
Sebastian Amigorena

Unit Director of U932 - Immunity and Cancer
Institut Curie
Epigenetic control of memory T cell responses
12:00 AM

Benoît Van den Eynde
Benoît Van den Eynde

Director, Brussels Branch
Ludwig Institute for Cancer Research
Apoptosis of tumour-infiltrating lymphocytes as a druggable immune checkpoint
3:15 PM

Mohamed Lamkanfi
Mohamed Lamkanfi

Head of Innate Immunity
Johnson & Johnson
New insights into inflammasome-induced autoinflammatory disease
1:30 PM

Ludovic Bourré
Ludovic Bourré

Director of Scientific Engagement
Crown Bioscience
Immuno-oncology: Strategies for applying humanised models
11:30 AM

Michal Bassani-Sternberg
Michal Bassani-Sternberg

Group Leader, Human Integrated Tumor Immunology Discovery Engine, UNIL/CHUV
Immunopeptidomics: Accelerating the development of personalised cancer immunotherapy
3:45 PM

The symposium will be held on the Janssen research campus in Beerse, Belgium on June 20th, 2018. Attendance is free of charge, on a first come first serve basis, with registration for the event mandatory.

In addition to the scientific sessions, there will be ample opportunities to network during coffee breaks, the provided conference lunch and closing reception

Register Now!

Register Now

Your privacy is important to us.
We'll never share your information.